← Leaderboards
Ming You
Ohio State University
$26,875,453
Attributed
$36,485,406
Total exposure
28
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$47,395,522 · 29
By mechanism
R01$33,813,758 · 19
U19$10,910,116 · 1
N01$2,463,621 · 3
R41$155,563 · 1
P41$37,464 · 4
R13$15,000 · 1
Top collaborators
- Pengyuan Liu12 shared
- Balaraman Kalyanaraman11 shared
- Ming Hu6 shared
- Haris G. Vikis6 shared
- Stuart J Wong6 shared
- Christopher I. Amos5 shared
- Laura A. Kresty5 shared
- Loic Le Marchand5 shared
Others in their field
Top investigators on “Lung Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$351,628,955
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,374,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,110,512
- William J. Blot · Vanderbilt University$59,429,890
- Charles A Coltman · Southwest Oncology Group$54,703,213
Research focus
Lung NeoplasmsMalignant Neoplasm Of LungTumorMouse ModelChemopreventionLungPreventLung TumorigenesisChemopreventive AgentCarcinogenesisDesignBaseA/J MouseAllelesLung AdenocarcinomaClinical TrialsFuturePre-ClinicalMediatingIn VitroPreventiveIn VivoDoseLaboratory Mouse
Grant awards (110)
Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis$625,471
R01 · FY2025 · CA · contact PI
Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis$645,107
R01 · FY2024 · CA · contact PI
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$383,989
R01 · FY2023 · CA · contact PI
Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer$668,650
R01 · FY2022 · CA · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$471,422
R01 · FY2022 · CA · contact PI
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$383,991
R01 · FY2022 · CA · contact PI
Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer$713,044
R01 · FY2021 · CA · contact PI
Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol$523,684
R01 · FY2021 · CA · contact PI
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$422,579
R01 · FY2021 · CA · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$403,481
R01 · FY2021 · CA · contact PI
Chemoprevention of lung cancer with mitochondria-targeted honokiol$115,136
R01 · FY2021 · CA · contact PI
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer$640,450
R01 · FY2020 · CA · contact PI
Chemoprevention of lung cancer with mitochondria-targeted honokiol$638,820
R01 · FY2020 · CA · contact PI
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$382,111
R01 · FY2020 · CA · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$183,047
R01 · FY2020 · CA · contact PI
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer$621,239
R01 · FY2019 · CA · contact PI
Chemoprevention of lung cancer with mitochondria-targeted honokiol$619,654
R01 · FY2019 · CA · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$481,383
R01 · FY2019 · CA · contact PI
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$378,872
R01 · FY2019 · CA · contact PI
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer$653,885
R01 · FY2018 · CA · contact PI
Chemoprevention of lung cancer with mitochondria-targeted honokiol$627,013
R01 · FY2018 · CA · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$504,001
R01 · FY2018 · CA · contact PI
EFFECT OF A MULTIPEPTIDE KRAS VACCINE IN THE PREVENTION OF PANCREATIC CANCER DRIVEN BY KRAS ONCOPROTEIN HHSN2612015000371 TORFP: 2017-E02$800,994
N01 · FY2017 · CA · contact PI
Chemoprevention of lung cancer with mitochondria-targeted honokiol$620,971
R01 · FY2017 · CA · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$525,681
R01 · FY2017 · CA · contact PI
IGF::OT::IGF RATIONAL DESIGN AND DEVELOPMENT OF A MULTI-ANTIGEN, MULTI-PEPTIDE VACCINE BASED ON GENOMIC INFORMATION TO PREVENT LUNG CANCER INITIATION AND PROGRESSIONHHSN2612015000371$630,760
N01 · FY2016 · CA · contact PI
IGF::OT::IGF LUNG CANCER CHEMOPREVENTION BY MICRORNA DELIVERY$377,621
N01 · FY2016 · CA · contact PI
Transdisciplinary Research in Cancer of the Lung (TRICL)$453,590
U19 · FY2014 · CA
Transdisciplinary Research in Cancer of the Lung (TRICL)$2,389,224
U19 · FY2013 · CA
Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer$415,792
R01 · FY2013 · CA · contact PI
MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE$289,474
R01 · FY2013 · CA · contact PI
Transdisciplinary Research in Cancer of the Lung (TRICL)$2,636,071
U19 · FY2012 · CA
Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer$448,167
R01 · FY2012 · CA · contact PI
Chemoprevention of lung cancer with red ginseng extracts$418,045
R01 · FY2012 · AT · contact PI
MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE$307,951
R01 · FY2012 · CA · contact PI
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E$277,762
R01 · FY2012 · CA
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E$30,657
R01 · FY2012 · CA
Transdisciplinary Research in Cancer of the Lung (TRICL)$2,612,327
U19 · FY2011 · CA
Chemoprevention of lung cancer with red ginseng extracts$462,108
R01 · FY2011 · AT · contact PI
Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer$454,179
R01 · FY2011 · CA · contact PI
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E$308,218
R01 · FY2011 · CA
MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE$307,951
R01 · FY2011 · CA · contact PI
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL$6,075
P41 · FY2011 · RR · contact PI
Transdisciplinary Research in Cancer of the Lung (TRICL)$2,818,904
U19 · FY2010 · CA
Chemoprevention of lung cancer with red ginseng extracts$486,114
R01 · FY2010 · AT · contact PI
Chemoprevention of Lung Cancer with Anti-tumor B$365,038
R01 · FY2010 · AT · contact PI
Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer$357,237
R01 · FY2010 · CA · contact PI
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E$315,400
R01 · FY2010 · CA
Chemoprevention with mTOR & Farnesyltransferase Inhibitors$217,624
R01 · FY2010 · CA · contact PI
MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE$210,375
R01 · FY2010 · CA · contact PI
Molecular Characterization of Stage I Lung Cancer$168,191
R01 · FY2010 · CA · contact PI
Molecular Characterization of Stage I Lung Cancer$159,437
R01 · FY2010 · CA · contact PI
MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE$106,400
R01 · FY2010 · CA · contact PI
Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer$63,840
R01 · FY2010 · CA · contact PI
Chemoprevention with mTOR & Farnesyltransferase Inhibitors$44,644
R01 · FY2010 · CA · contact PI
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL$9,710
P41 · FY2010 · RR · contact PI
Chemoprevention of lung cancer with red ginseng extracts$512,870
R01 · FY2009 · AT · contact PI
Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer$442,652
R01 · FY2009 · CA · contact PI
Chemoprevention of Lung Cancer with Anti-tumor B$368,725
R01 · FY2009 · AT · contact PI
Molecular Characterization of Stage I Lung Cancer$327,529
R01 · FY2009 · CA · contact PI
MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE$315,400
R01 · FY2009 · CA · contact PI
CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E$315,400
R01 · FY2009 · CA · contact PI
Chemoprevention with mTOR & Farnesyltransferase Inhibitors$261,975
R01 · FY2009 · CA · contact PI
Molecular genetics of Mouse Lung Tumors$248,200
R01 · FY2009 · CA · contact PI
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL$8,730
P41 · FY2009 · RR · contact PI
Chemoprevention of Lung Cancer with Anti-tumor B$368,725
R01 · FY2008 · AT · contact PI
Molecular Characterization of Stage I Lung Cancer$340,529
R01 · FY2008 · CA · contact PI
Identification of Pulmonary Lung Tumor Resistance 1 QTL Candidates$337,654
R01 · FY2008 · ES · contact PI
Chemoprevention with mTOR & Farnesyltransferase Inhibitors$261,976
R01 · FY2008 · CA · contact PI
Molecular genetics of Mouse Lung Tumors$248,200
R01 · FY2008 · CA · contact PI
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL$12,949
P41 · FY2008 · RR · contact PI
Chemoprevention of Lung Cancer with Anti-tumor B$389,250
R01 · FY2007 · AT · contact PI
Identification of Pulmonary Lung Tumor Resistance 1 QTL Candidates$344,545
R01 · FY2007 · ES · contact PI
Positioning Cloning of Lung Cancer Modifier Gene Par2$322,765
R01 · FY2007 · CA · contact PI
Chemoprevention with mTOR & Farnesyltransferase Inhibitors$262,177
R01 · FY2007 · CA · contact PI
Molecular genetics of Mouse Lung Tumors$248,200
R01 · FY2007 · CA · contact PI
Identification of Pulmonary Lung Tumor Resistance 1 QTL Candidates$354,836
R01 · FY2006 · ES · contact PI
Positionaing Cloning of Lung Cancer Modifier Gene Par2$332,425
R01 · FY2006 · CA · contact PI
MECHANISM OF MOUSE LUNG CARCINOGENESIS$328,586
R01 · FY2006 · CA · contact PI
Genetic Basis of Lung Tumor Progression in Mice$299,182
R01 · FY2006 · CA · contact PI
Chemoprevention with mTOR & Farnesyltransferase Inhibitors$284,013
R01 · FY2006 · CA · contact PI
Positional Cloning of the Pas 1 QTL in mice$283,869
R01 · FY2006 · ES · contact PI
Molecular genetics of Mouse Lung Tumors$255,613
R01 · FY2006 · CA · contact PI
Identification of Pulmonary Lung Tumor Resistance 1 QTL Candidates$363,375
R01 · FY2005 · ES
Positionaing Cloning of Lung Cancer Modifier Gene Par2$340,425
R01 · FY2005 · CA
MECHANISM OF MOUSE LUNG CARCINOGENESIS$334,621
R01 · FY2005 · CA
Genetic Basis of Lung Tumor Progression in Mice$306,383
R01 · FY2005 · CA
Positional Cloning of the Pas 1 QTL in mice$290,700
R01 · FY2005 · ES
Molecular genetics of Mouse Lung Tumors$275,014
R01 · FY2005 · CA
CHEMOPREVENTION OF LUNG CANCER IN MICE$385,293
R01 · FY2004 · CA
Identification of Pulmonary Lung Tumor Resistance 1 QTL Candidates$363,375
R01 · FY2004 · ES
Positionaing Cloning of Lung Cancer Modifier Gene Par2$340,425
R01 · FY2004 · CA
MECHANISM OF MOUSE LUNG CARCINOGENESIS$331,573
R01 · FY2004 · CA
Genetic Basis of Lung Tumor Progression in Mice$306,383
R01 · FY2004 · CA
Positional Cloning of the Pas 1 QTL in mice$290,700
R01 · FY2004 · ES
CHEMOPREVENTION OF LUNG CANCER IN MICE$374,070
R01 · FY2003 · CA
Positioning Cloning of Lung Cancer Modifier Gene Par2$340,425
R01 · FY2003 · CA
MECHANISM OF MOUSE LUNG CARCINOGENESIS$323,464
R01 · FY2003 · CA
Genetic Basis of Lung Tumor Progression in Mice$306,383
R01 · FY2003 · CA
Positional Cloning of the Pas 1 QTL in mice$290,700
R01 · FY2003 · ES
CHEMOPREVENTION OF LUNG CANCER IN MICE$376,650
R01 · FY2002 · CA
MOLECULAR GENETICS OF MOUSE LUNG TUMORS$325,566
R01 · FY2002 · CA
MECHANISM OF MOUSE LUNG CARCINOGENESIS$286,926
R01 · FY2002 · CA
MECHANISM OF MOUSE LUNG CARCINOGENESIS$44,338
R01 · FY2002 · CA
MOLECULAR GENETICS OF MOUSE LUNG TUMORS$317,840
R01 · FY2001 · CA
Wild type Ras as cancer therapeutic agent$155,563
R41 · FY2001 · CA
SCREENING CHEMOPREVENTIVE AGENTS IN MICE WITH GREMLINE M$411,584
N01 · FY2000 · CN
MOLECULAR GENETICS OF MOUSE LUNG TUMORS$395,548
R01 · FY2000 · CA
PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS$242,662
N01 · FY2000 · CN
THIRD INTERNATIONAL MOUSE LUNG TUMORIGENESIS SYMPOSIUM$15,000
R13 · FY2000 · CA